The Fanconi Anemia/BRCA signaling pathway: disruption in cisplatin-sensitive ovarian cancers.

D'Andrea, Alan D

The Fanconi Anemia/BRCA signaling pathway: disruption in cisplatin-sensitive ovarian cancers. [electronic resource] - Cell cycle (Georgetown, Tex.) - 290-2 p. digital

Publication Type: Journal Article; Review

1538-4101


Antineoplastic Agents--pharmacology
BRCA1 Protein--genetics
Cell Nucleus--metabolism
Chromosomal Instability--physiology
Cisplatin--pharmacology
DNA Methylation--drug effects
DNA Repair--physiology
Fanconi Anemia--drug therapy
Fanconi Anemia Complementation Group F Protein
Female
Histone Acetyltransferases
Histone Chaperones
Humans
Nuclear Proteins--genetics
Ovarian Neoplasms--drug therapy
RNA-Binding Proteins--genetics
Signal Transduction--drug effects